PT87250A - Novel 2beta-morpholino-androstane derivatives and processes for their preparation - Google Patents

Novel 2beta-morpholino-androstane derivatives and processes for their preparation

Info

Publication number
PT87250A
PT87250A PT87250A PT8725088A PT87250A PT 87250 A PT87250 A PT 87250A PT 87250 A PT87250 A PT 87250A PT 8725088 A PT8725088 A PT 8725088A PT 87250 A PT87250 A PT 87250A
Authority
PT
Portugal
Prior art keywords
2beta
morpholino
novel
processes
preparation
Prior art date
Application number
PT87250A
Other languages
English (en)
Other versions
PT87250B (pt
Inventor
Thomas Sleigh
David Samuel Savage
Ian Graig Carlyle
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of PT87250A publication Critical patent/PT87250A/pt
Publication of PT87250B publication Critical patent/PT87250B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Underground Structures, Protecting, Testing And Restoring Foundations (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT87250A 1987-04-14 1988-04-14 Processo de preparacao de derivados 2beta-morfolino-androstano e de composicoes farmaceuticas que os contem PT87250B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878708886A GB8708886D0 (en) 1987-04-14 1987-04-14 2beta-morpholino-androstane derivatives

Publications (2)

Publication Number Publication Date
PT87250A true PT87250A (pt) 1988-05-01
PT87250B PT87250B (pt) 1992-08-31

Family

ID=10615781

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87250A PT87250B (pt) 1987-04-14 1988-04-14 Processo de preparacao de derivados 2beta-morfolino-androstano e de composicoes farmaceuticas que os contem

Country Status (19)

Country Link
US (1) US4894369A (pt)
EP (1) EP0287150B1 (pt)
JP (1) JPH0753751B2 (pt)
KR (2) KR0130208B1 (pt)
AT (1) ATE79631T1 (pt)
AU (1) AU608313B2 (pt)
CA (1) CA1291117C (pt)
DE (2) DE3873803T2 (pt)
DK (1) DK174743B1 (pt)
ES (1) ES2043781T3 (pt)
FI (1) FI89057C (pt)
GB (1) GB8708886D0 (pt)
GR (1) GR3006275T3 (pt)
HU (1) HU198738B (pt)
IE (1) IE63672B1 (pt)
NL (1) NL940010I2 (pt)
NZ (1) NZ224228A (pt)
PT (1) PT87250B (pt)
ZA (1) ZA882481B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709565D0 (en) * 1987-04-23 1987-05-28 Akzo Nv 2beta,16beta-diaminoandrostanes
HU210076B (en) * 1992-11-02 1995-01-30 Tuba Process for producing androstane derivatives substituted with quaternisaeted amino group in 16-position and for producing pharmaceutical compositions containing them
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US7579461B2 (en) * 2004-01-15 2009-08-25 Chemagis Ltd. Processes for the preparation of rocuronium bromide and intermediates thereof
US20060058276A1 (en) * 2004-07-15 2006-03-16 Oded Friedman Processes for the preparation and purification of rocuronium bromide
US20060058275A1 (en) * 2004-07-15 2006-03-16 Oded Friedman Processes for preparing stabilized, highly pure rocuronium bromide
US20060009485A1 (en) * 2005-06-23 2006-01-12 Chemagis Ltd Method of reprocessing quaternary ammonium-containing neuromuscular blocking agents
EP1828221B2 (en) 2005-09-13 2013-12-25 Sicor Inc. Process for the preparation of pure rocuronium bromide
GB2445746A (en) * 2007-01-17 2008-07-23 Texcontor Ets Use of carbonated water as a solvent for freeze drying, and method of purification comprising dissolution of material in carbonated water and freeze drying
CN101125878B (zh) * 2007-09-30 2011-01-12 浙江仙琚制药股份有限公司 甾体类肌松药物罗库溴铵的制备方法
CN101863948B (zh) * 2009-04-17 2013-07-24 重庆医药工业研究院有限责任公司 高纯度(2β,3α,5α,16β,17β)-2-(4-吗啉基)-16-(1-吡咯烷基)-雄甾烷-3,17-二醇或其组合物及其制备方法
CN101824066B (zh) * 2010-04-08 2012-06-13 浙江仙琚制药股份有限公司 制备罗库溴铵中间体化合物结晶物的方法
CN103119051B (zh) * 2011-01-26 2015-09-23 浙江华海药业股份有限公司 罗库溴铵的制备方法
EP2703408B1 (en) 2011-04-25 2015-08-26 Zhejiang Huahai Pharmaceutical Co., Ltd. Method for purifying rocuronium bromide
AU2014285324B2 (en) 2013-07-01 2019-05-23 Maruishi Pharmaceutical Co., Ltd. Rocuronium preparation causing less pain, method for producing the same, and method for reducting and/or alleviating vascular pain to be induced using the same
CN105566433A (zh) * 2016-01-15 2016-05-11 安徽悦康凯悦制药有限公司 一种罗库溴铵的生产工艺
CN108570090B (zh) * 2018-05-25 2021-02-02 江苏盈科生物制药有限公司 一种高纯度罗库溴铵的制备方法
CN110734468B (zh) 2018-07-20 2021-04-16 济南高德医药科技有限公司 罗库溴铵粗品的精制方法
CN110240624B (zh) * 2019-08-01 2020-06-09 天津红日药业股份有限公司 一种雄甾烷衍生物及其制备方法与应用
CN111057122B (zh) * 2019-12-25 2021-04-30 武汉华龙生物制药有限公司 一种罗库溴铵的制备方法
CN112110880B (zh) * 2020-09-29 2022-09-09 天津红日药业股份有限公司 雄甾烷衍生物及其制备方法与应用
CN114088842B (zh) * 2021-11-19 2023-03-21 江苏正济药业股份有限公司 一种罗库溴铵中间体及杂质的检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138605A (en) * 1965-02-19 1969-01-01 Organon Labor Ltd Improvements in or relating to new 2-ß,16-ß-diamino-androstanes
GB1454749A (en) * 1972-11-29 1976-11-03 Akzo Nv 2beta, 16beta-diamino-androstanes and their preparation
IE53463B1 (en) * 1981-06-15 1988-11-23 Akzo Nv Mono-and bisquaternary ammonium derivatives of 2 beta,16 beta-d-amino-5 alpha-androstane derivatives and pharmaceutical preparations containing same
GB8709565D0 (en) * 1987-04-23 1987-05-28 Akzo Nv 2beta,16beta-diaminoandrostanes

Also Published As

Publication number Publication date
CA1291117C (en) 1991-10-22
KR19980078895A (ko) 1998-11-25
GB8708886D0 (en) 1987-05-20
DE3873803D1 (de) 1992-09-24
DK202888A (da) 1988-10-15
GR3006275T3 (pt) 1993-06-21
DE3873803T2 (de) 1993-06-24
IE63672B1 (en) 1995-05-31
KR100221116B1 (ko) 1999-10-01
HUT47595A (en) 1989-03-28
NL940010I2 (nl) 1997-10-01
ATE79631T1 (de) 1992-09-15
ZA882481B (en) 1988-09-29
HU198738B (en) 1989-11-28
US4894369A (en) 1990-01-16
EP0287150A1 (en) 1988-10-19
JPS63277693A (ja) 1988-11-15
FI89057C (fi) 1993-08-10
EP0287150B1 (en) 1992-08-19
AU1457088A (en) 1988-10-20
AU608313B2 (en) 1991-03-28
DK202888D0 (da) 1988-04-13
DK174743B1 (da) 2003-10-13
KR880012632A (ko) 1988-11-28
ES2043781T3 (es) 1994-01-01
JPH0753751B2 (ja) 1995-06-07
IE881017L (en) 1988-10-14
NL940010I1 (nl) 1994-07-18
FI89057B (fi) 1993-04-30
FI881707A0 (fi) 1988-04-13
FI881707A (fi) 1988-10-15
KR0130208B1 (ko) 1998-04-03
NZ224228A (en) 1990-03-27
PT87250B (pt) 1992-08-31
DE19575040I2 (de) 2003-09-18

Similar Documents

Publication Publication Date Title
PT87250A (pt) Novel 2beta-morpholino-androstane derivatives and processes for their preparation
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
DE3873167D1 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
FI890477A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI864970A (fi) Nya kristallina salter av aryloxi-propanolaminer, foerfarande foer deras framstaellning och deras anvaendning.
ES2061724T3 (es) Derivados de sacarido.
IL87561A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
ATA392484A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydrothiazolo(5,4-c)pyridinderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FI900098A0 (fi) Menetelmä lääkeaineena käyttökelpoisten 5H-pyrido/1',2':4,5/tiadiatsino/2,3-a/bentsimidatsoliumjohdannaisten valmistamiseksi
ATA19777A (de) Verfahren zur herstellung von neuen thieno (3,2-c)pyridinderivaten und deren saeure- additionssalzen
DK9588A (da) 2,1-benzothiazepin-2,2-dioxid-5-carboxylsyrederivater
AT352136B (de) Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b) -isochinolin-derivaten und von deren saeure- additionssalzen
IT1191937B (it) Comfigurazione elettroottica per la generazione d'impulsi laser ultracorti
GR880100196A (el) Υποκατεστημενα 1,3-διοξολαν-και 1,3-διοξαν-παραγωγα,μεθοδοι για την παρασκευη τους και η χρηση τους
SE8303400D0 (sv) Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning
IT8149311A0 (it) Derivati benzanilidici dotati di attivita' farmacologica e procedimento per la loro produzione
SE7600418L (sv) Forfarande for framstellning av 3,5-dimetylbensoesyraderivat och salter derav
OA07646A (fr) Nouveaux dérivés hétérocycliques substitués par un radical animé, leurs procédés d'obtention et les compositions pharmaceutiques en renfermant.
AT349022B (de) Verfahren zur herstellung von neuen, gegebenenfalls optisch aktiven 2-hydroxyimino- 1,2,3,4,6,7-hexahydro-11bh-benzo(a)chinolizin -derivaten, deren saeureadditionssalzen und quaternaeren salzen

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920204

PC4A Transfer of assignment

Owner name: N.V. ORGANON, NL

Effective date: 20061124

PD4A Change of proprietorship

Owner name: AKZO NOBEL N.V., NL

Effective date: 20061128

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20080414